Skip to main content
. 2020 Aug 4;2(5):100169. doi: 10.1016/j.jhepr.2020.100169

Fig. 2.

Fig. 2

Summary of recommendations.

ACLF, acute-on-chronic liver failure; COVID-19, coronavirus disease 2019; HCC, hepatocellular carcinoma; LT, liver transplant; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.